#BioNTech SE (BNTX) - Prohost Biotech

BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field

BioNTech in the NEWS MAINZ, Germany, December 18, 2025 – BioNTech SE ( BNTX ) announced the closing of its acquisition of CureVac N.V. ( CVAC ) and that the subsequent offering period (the of the for...

P

Prohost Biotech

Dec 18, 2025

Why BioNTech Acquiring CureVac Is Good News For BioNTech

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer We wanted to know the reason for the acquisition so we looked at the BioNTech press release about the acquisition a...

P

Prohost Biotech

Jun 30, 2025

Why We Believe That BioNTech Will Have A Great Future

Biotechnology and biopharmaceutical firms were doing great until the day the COVID-19 pandemic changed the lives of the world's population, killing millions worldwide. This distress impacted humanity'...

P

Prohost Biotech

Jun 18, 2025

Gilead Sciences: A Promising Acquisition. See Also: Genmab and BioNTech: A Promising Expansion

Gilead Sciences to Acquire MiroBio At $405 Million Gilead Sciences ( GILD ) and MiroBio - a privately held U.K based biotechnology company focused on restoring immune balance with agonists targeting i...

P

Prohost Biotech

Aug 5, 2022

CureVac Lawsuit Against BioNTech and Subsidiaries, Seeking Fair Compensation for Infringement of Intellectual Property

CureVac N.V. Files Lawsuit Against BioNTech for Infringement CureVac N.V. ( CVAC ), a company that develops therapeutics based on messenger ribonucleic acid ( mRNA ), has moved to assert its intellec...

P

Prohost Biotech

Jul 5, 2022

Gilead Sciences: The FDA Lifts Partial Clinical Hold on MDS and AML Magrolimab Studies. See Also: BioNTech

FDA Lifts Partial Clinical Hold on Gilead Sciences Studies of Magrolimab On April 12, 2022, Gilead Sciences ( GILD ) announced that the U.S. FDA lifted the partial clinical hold placed on studies eval...

P

Prohost Biotech

Apr 13, 2022

We Are Back

We Are Back! Thanks to God. Hello to all our subscribers. Our sickness was unanticipated, making our year start in February rather than January. We will tackle the sickness later in another article. N...

P

Prohost Biotech

Feb 1, 2022

CureVac N.V.

Prohost Portfolio PLUS #3 CureVac N.V. We were looking forward to learning more important details about the German firm, CureVac N.V. ( CVAC ) , when the company announced business updates and financi...

P

Prohost Biotech

Apr 18, 2021

Why Intellia Therapeutics' and Moderna's Stocks Moved South Yesterday

Intellia Therapeutics Intellia Therapeutics ( NTLA ) stock price headed south probably because some robots learned that the firm commenced an underwritten public offering of $150 million of shares of...

P

Prohost Biotech

Dec 2, 2020

A New COVID-19 Vaccine is Showing Successful Results. See Also: More Details About the Effective COVID-19 Vaccines

COVID-19 Vaccine Updates Pfizer's ( PFE ) /BioNTech's ( BNTX ) and Moderna's ( MRNA ) COVID-19 vaccines have demonstrated safety at around 95% efficacy. AstraZeneca ( AZN ) and Oxford University ann...

P

Prohost Biotech

Nov 23, 2020

Pfizer and BioNTech Submitted an EUA to the FDA for their COVID-19 Vaccine, BNT162b2

Pfizer, BioNTech & Moderna When asked whether we heard the news about the submission of the Emergency Use Authorization (EUA) and whether we will inform our readers about it. Our answer was that we ha...

P

Prohost Biotech

Nov 21, 2020

1m

7

News & Comments

Pfizer and BioNTech Vaccine Candidate Against COVID-19 Achieved a Sweet Success

Pfizer and BioNTech Good News Regarding COVID-19 Vaccine Candidate Pfizer (PFE) and BioNTech (BNTX) announced that their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 (the virus that caus...

P

Prohost Biotech

Nov 9, 2020

6m

1

News & Comments

Tracking COVID-19 Vaccines

COVID-19 Vaccines from Pfizer/BioNTech and Moderna The three products whose trials were halted are not vaccines but, rather, antibodies that treat patients who already have COVID-19. With regard to th...

P

Prohost Biotech

Oct 16, 2020

SARS-CoV-2 Virus vs The President of the United States

President Trump, the First Lady and COVID-19 Indeed, the complicated, nasty SARS-CoV-2 virus managed to infect President Trump and the First Lady when we were expecting a vaccine to soon be ready to p...

P

Prohost Biotech

Oct 5, 2020

The Whole World Against the Blind SARS-CoV-2 Virus

Prohost Letter 442 The Whole World Against the Blind SARS-CoV-2 Virus Investors have no doubt profited from the developers of COVID-19 vaccines which include: Moderna ( MRNA ), Novavax ( NVAX ) and Bi...

P

Prohost Biotech

Sep 28, 2020

1m

3

News & Comments

The U.S. CDC Tells the 50 States to Prepare for COVID-19 Vaccines by the End of October

CDC Is Asking States to Prepare for COVID-19 Vaccines The U.S. Center of Disease Control and Prevention (CDC) has asked the 50 states' public health officials to be ready to distribute potential COVID...

P

Prohost Biotech

Sep 3, 2020

There Is A Lot More To Say About the COVID-19 Vaccines

Pfizer and BioNTech Vaccines Were Granted FDA Fast Track Designation Against SARS-CoV-2 (COVID-19) A large Phase 2b/3 safety and efficacy study may begin as early as July 2020 Pfizer ( PFE ) and BioNT...

P

Prohost Biotech

Jul 13, 2020

Are We Saying Goodbye to Common Sense?

Prohost Letter #441 Biotechnology Companies’ Evaluations Are We Saying Goodbye to Common Sense? The SARS-CoV-2 Vaccines It is said that the difference between the SARS-CoV-2 coronavirus (COVID-19), wh...

P

Prohost Biotech

Jul 3, 2020

The COVID-19 Vaccines' Developing Firms' Bizarre Evaluations

Novel Coronavirus Vaccines and Wall Street Vaccines against novel coronavirus are recognized now as the only way to return disrupted human lives back to normal. Vaccines have become the most important...

P

Prohost Biotech

Jun 26, 2020

Questions & Answers

The Week in Review #51 Questions & Answers About CytomX Q: Is there any reason for the CytomX stock selloff that occurred in early May? In order to answer this question we need to explain CytomX’s ( C...

P

Prohost Biotech

May 27, 2020

1m

2